Beijing Bayi Space LCD Technology Co (688181) Fair Value & Analysis
Technology · CN · Market cap 5.9B CNY
Analysis
Beijing Bayi Space LCD Technology Co (688181) currently trades at ¥48.50, while our model-based Fair Value estimate is ¥11.74 — implying the stock looks roughly 75.8% overvalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Beijing Bayi Space LCD Technology Co.,Ltd. researches, develops, produces, and sells display materials in China. It also offers semiconductor and pharmaceutical materials. The company also provides liquid crystal, polymer dispersed liquid crystal (PDLC) smart films, and organic electroluminescent materials (OLED); semiconductor materials includes photoresist resin materials and polyimide; and pharmaceutical materials, such as advanced pharmaceutical intermediates and APIs, as well as offers liquid crystal materials. In addition, it offers mixed liquid crystal; monomer liquid crystals, including ester liquid, flaming LCD, alkene liquid, negative liquid, fluorine-containing liquids, phenylcyclohexane liquids, chiral liquid, difluoromethoxy liquids, biphenyl liquid, acrylic liquids, bicyclohexane liquids; and OLED and intermediate materials. Its products are used in various applications, including mobile phones, laptops, computer monitors, and televisions. The company is also involved …
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.